Djabarouti S[Author] - Search Results

Year	Number of Results
2003	1
2004	4
2005	2
2006	1
2007	2
2009	2
2010	2
2011	1
2012	2
2013	1
2014	1
2017	1
2019	2
2020	1
2021	2
2022	2
2023	2
2024	0

1

Real-World Experience with a Human Fibrinogen Concentrate: Clinical Data from Adult and Pediatric Patients Requiring Fibrinogen for Bleeding Control and Prevention.

Stéphan F, Gutermann L, Bourget S, Djabarouti S, Berdugo J, Fardini Y, Clerson P, Hébert G, Belmokhtar C. Stéphan F, et al. Among authors: djabarouti s. J Clin Pharmacol. 2023 Nov;63(11):1186-1196. doi: 10.1002/jcph.2291. Epub 2023 Jul 30. J Clin Pharmacol. 2023. PMID: 37293880

2

[Benefit of therapeutic drug monitoring of immunosuppressants and immunomodulators in the management of autoimmune diseases].

Djabarouti S, Mora P, Lahouati M, Gigan M, d'Houdain N, Sourisseau B, Chambord J, Xuereb F. Djabarouti S, et al. Rev Med Interne. 2022 Jul;43(7):412-418. doi: 10.1016/j.revmed.2022.03.343. Epub 2022 May 25. Rev Med Interne. 2022. PMID: 35643786 French.

3

Measurement of the Immunosuppressant Possession Ratio by Transplant Clinical Pharmacists Captures a Non-Adherence Associated With Antibody-Mediated Rejection.

Chambord J, Chauveau B, Djabarouti S, Vignaud J, Taton B, Moreau K, Visentin J, Merville P, Xuereb F, Couzi L. Chambord J, et al. Among authors: djabarouti s. Transpl Int. 2023 Nov 28;36:11962. doi: 10.3389/ti.2023.11962. eCollection 2023. Transpl Int. 2023. PMID: 38089004 Free PMC article.

4

Implementation of infliximab standardized doses after pharmacokinetic modelization in a cohort of patients with Crohn's disease.

Poullenot F, Ollivier J, Rivière P, Sauvaget L, Berroneau A, Djabarouti S, Xuereb F, Zerbib F, Breilh D, Laharie D. Poullenot F, et al. Among authors: djabarouti s. Dig Liver Dis. 2020 Apr;52(4):408-413. doi: 10.1016/j.dld.2019.11.018. Epub 2019 Dec 23. Dig Liver Dis. 2020. PMID: 31874834

5

Benefit of a pharmacist-led intervention for medication management of renal transplant patients: a controlled before-and-after study.

Chambord J, Couzi L, Merville P, Moreau K, Xuereb F, Djabarouti S. Chambord J, et al. Among authors: djabarouti s. Ther Adv Chronic Dis. 2021 Apr 5;12:20406223211005275. doi: 10.1177/20406223211005275. eCollection 2021. Ther Adv Chronic Dis. 2021. PMID: 33868624 Free PMC article.

6

Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).

Duvignaud A, Lhomme E, Onaisi R, Sitta R, Gelley A, Chastang J, Piroth L, Binquet C, Dupouy J, Makinson A, Lefèvre B, Naccache JM, Roussillon C, Landman R, Wallet C, Karcher S, Journot V, Nguyen D, Pistone T, Bouchet S, Lafon ME, Molimard M, Thiébaut R, de Lamballerie X, Joseph JP, Richert L, Saint-Lary O, Djabarouti S, Wittkop L, Anglaret X, Malvy D; Coverage Study Group. Duvignaud A, et al. Among authors: djabarouti s. Clin Microbiol Infect. 2022 Jul;28(7):1010-1016. doi: 10.1016/j.cmi.2022.02.031. Epub 2022 Mar 15. Clin Microbiol Infect. 2022. PMID: 35304280 Free PMC article. Clinical Trial.

7

Are Standard Dosing Regimens of Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance?

Ollivier J, Carrié C, d'Houdain N, Djabarouti S, Petit L, Xuereb F, Legeron R, Biais M, Breilh D. Ollivier J, et al. Among authors: djabarouti s. Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02134-18. doi: 10.1128/AAC.02134-18. Print 2019 Mar. Antimicrob Agents Chemother. 2019. PMID: 30602511 Free PMC article.

8

Long-term physicochemical stability of acyclovir 5 mg/mL solution stored in polypropylene bags as a simulated hospital stock preparation.

Legeron R, Bougueon G, Berroneau A, De-Germay S, Bernadou JM, Djabarouti S, Crauste-Manciet S, Xuereb F. Legeron R, et al. Among authors: djabarouti s. Am J Health Syst Pharm. 2021 Apr 22;78(9):806-812. doi: 10.1093/ajhp/zxab071. Am J Health Syst Pharm. 2021. PMID: 33630992

9

Diffusion of levofloxacin into bone and synovial tissues.

Rimmelé T, Boselli E, Breilh D, Djabarouti S, Bel JC, Guyot R, Saux MC, Allaouchiche B. Rimmelé T, et al. Among authors: djabarouti s. J Antimicrob Chemother. 2004 Mar;53(3):533-5. doi: 10.1093/jac/dkh110. Epub 2004 Feb 12. J Antimicrob Chemother. 2004. PMID: 14963066 Clinical Trial.

10

Pre-dose plasma concentration monitoring of mycophenolate mofetil in patients with autoimmune diseases.

Streicher C, Djabarouti S, Xuereb F, Lazaro E, Legeron R, Bouchet S, Greib C, Breilh D, Pellegrin JL, Viallard JF. Streicher C, et al. Among authors: djabarouti s. Br J Clin Pharmacol. 2014 Dec;78(6):1419-25. doi: 10.1111/bcp.12462. Br J Clin Pharmacol. 2014. PMID: 25041114 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year